Product NDC: | 63323-269 |
Proprietary Name: | Diprivan |
Non Proprietary Name: | PROPOFOL |
Active Ingredient(s): | 10 mg/mL & nbsp; PROPOFOL |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, EMULSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-269 |
Labeler Name: | Fresenius Kabi USA, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019627 |
Marketing Category: | NDA |
Start Marketing Date: | 20091113 |
Package NDC: | 63323-269-65 |
Package Description: | 10 VIAL in 1 BOX (63323-269-65) > 100 mL in 1 VIAL |
NDC Code | 63323-269-65 |
Proprietary Name | Diprivan |
Package Description | 10 VIAL in 1 BOX (63323-269-65) > 100 mL in 1 VIAL |
Product NDC | 63323-269 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | PROPOFOL |
Dosage Form Name | INJECTION, EMULSION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20091113 |
Marketing Category Name | NDA |
Labeler Name | Fresenius Kabi USA, LLC |
Substance Name | PROPOFOL |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |